Financhill
Back

Chemed Quote, Financials, Valuation and Earnings

Chemed Price Quote

$522.34
-0.82 (0.11%)
(Updated: December 21, 2024 at 5:20 AM ET)

Chemed Key Stats

Sell
32
Chemed (CHE) is a Sell

Day range:
$520.00 - $526.21
52-week range:
$516.91 - $654.62
Dividend yield:
0.34%
P/E ratio:
29.18
P/S ratio:
3.36
P/B ratio:
6.34%

Volume:
205.3K
Avg. volume:
96.4K
1-year change:
-10.1%
Market cap:
$7.8B
Revenue:
$2.3B
EPS:
$19.79

How Much Does Chemed Make?

Data Unavailable

Is Chemed Growing As A Company?

Data Unavailable

Chemed Stock Price Performance

  • Did Chemed Stock Go Up Last Month?
    Chemed share price went down by -5.37% last month
  • Did CHE's Share Price Rise Over The Last Year?
    CHE share price fell by -10.1% over the past 1 year

What Is Chemed 52-Week High & Low?

  • What Is Chemed’s 52-Week High Share Price?
    Chemed has traded as high as $654.62 over the past 52 weeks
  • What Is Chemed’s 52-Week Low Share Price?
    Chemed has traded as low as $516.91 over the past 52 weeks

Chemed Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Chemed?

Data Unavailable

Is Chemed Cash Flow Positive?

Data Unavailable

Chemed Return On Invested Capital

Data Unavailable

Chemed Earnings Date & Stock Price

  • What Is Chemed's Stock Price Today?
    A single share of CHE can be purchased today for 523.16
  • What Is Chemed’s Stock Symbol?
    Chemed trades on the nyse under the ticker symbol: CHE
  • When Is Chemed’s Next Earnings Date?
    The next quarterly earnings date for Chemed is scheduled on February 27, 2025
  • When Is CHE's next ex-dividend date?
    Chemed's next ex-dividend date is November 18, 2024
  • How To Buy Chemed Stock?
    You can buy Chemed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Chemed Competitors

  • Who Are Chemed's Competitors?
    Below is a list of companies who compete with Chemed or are related in some way:
    • Addus HomeCare Corp (ADUS)
    • Amedisys Inc (AMED)
    • Option Care Health Inc (OPCH)
    • OptimizeRx Corp (OPRX)
    • Regional Health Properties Inc (RHE)

Chemed Dividend Yield

Data Unavailable

Chemed Analyst Estimates

YoY Growth Past Surprise
EPS: 1.42% -2.08%
Revenue: 7.38% -0.99%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable